Page last updated: 2024-10-27

gentamicin and Intestinal Neoplasms

gentamicin has been researched along with Intestinal Neoplasms in 1 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Intestinal Neoplasms: Tumors or cancer of the INTESTINES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dineen, SP1
Pham, TH1
Murray, BW1
Parker, BJ1
Hartless, K1
Anthony, T1
Huerta, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Developing Evidence of Effectiveness for Adjuvant Interventions Designed to Minimize Surgical Site Infections[NCT01153191]120 participants (Anticipated)Interventional2010-08-31Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for gentamicin and Intestinal Neoplasms

ArticleYear
Feasibility of subcutaneous gentamicin and pressurized irrigation as adjuvant strategies to reduce surgical site infection in colorectal surgery: results of a pilot study.
    The American surgeon, 2015, Volume: 81, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Body Mass Index; Colore

2015